This patient has community-acquired pneumonia requiring inpatient admission. He has multiple comorbidities (COPD, diabetes). The standard of care for non-severe inpatient CAP is a combination of a beta-lactam (e.g., ceftriaxone) plus a macrolide (e.g., azithromycin), or monotherapy with a respiratory fluoroquinolone (e.g., levofloxacin). This regimen provides coverage for typical pathogens like Streptococcus pneumoniae as well as atypical pathogens.

This patient's presentation with pneumonia accompanied by gastrointestinal symptoms (diarrhea), neurologic symptoms (headache), and hyponatremia, in the context of a recent hotel stay, is classic for Legionnaires' disease, caused by Legionella pneumophila. The most rapid and specific diagnostic test is the urine antigen test for L. pneumophila serogroup 1.

This patient has an empyema, which is a complicated parapneumonic effusion characterized by the presence of pus or bacteria in the pleural space. The pleural fluid analysis (pH < 7.2, glucose < 60 mg/dL, positive Gram stain) confirms this. The definitive management for an empyema requires drainage of the infected fluid in addition to antibiotics. The first-line intervention for drainage is the placement of a chest tube (tube thoracostomy).

Optic neuritis, characterized by decreased visual acuity, central scotoma, and color blindness (especially red-green), is a well-known, dose-dependent adverse effect of ethambutol. This is a reversible condition if the drug is discontinued promptly. Patients starting ethambutol should have a baseline vision screen and be counseled to report any visual changes immediately.

This patient's subacute presentation, age, and setting (college dormitory) are classic for an atypical pneumonia, often referred to as 'walking pneumonia.' Mycoplasma pneumoniae is the most common cause of atypical pneumonia in young, healthy adults. The indolent course, non-productive cough, and interstitial pattern on chest x-ray are characteristic features.

This patient has severe community-acquired pneumonia, as evidenced by his need for ICU admission and vasopressor support for septic shock. Guidelines for severe CAP recommend a combination of a beta-lactam (e.g., ceftriaxone) plus a macrolide (e.g., azithromycin) or a beta-lactam plus a respiratory fluoroquinolone. This combination provides broad coverage against the most likely pathogen, Streptococcus pneumoniae (suggested by the Gram stain), as well as atypical pathogens.

This patient meets the criteria for ventilator-associated pneumonia (VAP), which develops >48 hours after endotracheal intubation. Empiric therapy for VAP must cover multidrug-resistant organisms, including MRSA and Pseudomonas aeruginosa. The combination of vancomycin (for MRSA) and an anti-pseudomonal beta-lactam such as piperacillin-tazobactam provides appropriate broad-spectrum coverage pending culture results.

The clinical presentation of subacute dyspnea, hypoxia, and diffuse interstitial infiltrates in a severely immunocompromised patient (CD4 < 200) is highly suggestive of Pneumocystis jirovecii pneumonia (PJP). Because P. jirovecii cannot be cultured, a definitive diagnosis requires visualization of the cysts or trophozoites in a respiratory sample. Sputum induction can be attempted, but bronchoscopy with bronchoalveolar lavage (BAL) has a much higher diagnostic yield and is the most appropriate next step.

This patient's presentation is classic for a lung abscess. Key features include the subacute onset of symptoms, risk factors for aspiration (alcoholism, poor dentition), production of purulent, foul-smelling (putrid) sputum indicative of anaerobic infection, and the characteristic chest x-ray finding of a cavitary lesion with an air-fluid level. The location in a gravity-dependent segment of the lung is also typical.

This patient is demonstrating clinical failure of outpatient pneumonia treatment. His worsening respiratory symptoms, persistent high fever, and new-onset confusion are signs of severe pneumonia that require hospitalization. He needs urgent evaluation in an emergency department for potential sepsis, respiratory failure, and the need for intravenous antibiotics and supportive care. Changing oral antibiotics would be inappropriate and unsafe.